Detecting diminished dopamine-firing cells inside brain could reveal earliest signs of Alzheimer's

by University of SheffieldPET scan of a human brain with Alzheimer's disease. Credit: public domainA new link between diminished input from dopamine-firing cells deep inside the brain and the

Updated on: June 20,2024

Detecting diminished dopamine-firing cells inside brain could reveal earliest signs of Alzheimer's

by University of SheffieldPET scan of a human brain with Alzheimer's disease. Credit: public domainA new link between diminished input from dopamine-firing cells deep inside the brain and the

Updated on:June 20,2024

'Making the best of it': Families face the heavy burden of Alzheimer's

by Alan Mozes, Healthday Reporter(HealthDay)—For Marilyn and Tom Oestreicher, their golden years were within reach.After more than four decades of marriage, the Illinois couple had fashioned a comfort

Updated on: March 13,2024

'Making the best of it': Families face the heavy burden of Alzheimer's

by Alan Mozes, Healthday Reporter(HealthDay)—For Marilyn and Tom Oestreicher, their golden years were within reach.After more than four decades of marriage, the Illinois couple had fashioned a comfort

Updated on:March 13,2024

The orchid and dandelion phenomenon in brain aging: Personalizing cognitive health approaches for older adults

Updated on: September 05,2024

The orchid and dandelion phenomenon in brain aging: Personalizing cognitive health approaches for older adults

Updated on:September 05,2024

Predicting change in the Alzheimer's brain

by Larry Hardesty,Massachusetts Institute of TechnologyMIT researchers are developing a computer system that uses genetic, demographic, and clinical data to help predict the effects of disease o

Updated on: February 26,2024

Predicting change in the Alzheimer's brain

by Larry Hardesty,Massachusetts Institute of TechnologyMIT researchers are developing a computer system that uses genetic, demographic, and clinical data to help predict the effects of disease o

Updated on:February 26,2024

No new drugs for Alzheimer's disease in 15 years

by Vanessa Jane Hall,ScienceNordicCredit: AI-generated imageHow often to you read headlines proclaiming the arrival of a new, ground-breaking treatment for Alzheimer's?The answer is probably

Updated on: March 13,2024

No new drugs for Alzheimer's disease in 15 years

by Vanessa Jane Hall,ScienceNordicCredit: AI-generated imageHow often to you read headlines proclaiming the arrival of a new, ground-breaking treatment for Alzheimer's?The answer is probably

Updated on:March 13,2024

Neurologist explains aphasia

by Deb Balzer, Mayo Clinic News NetworkCredit: CC0 Public DomainAphasia is a condition that can affect a person's ability to communicate.To better understand the condition, the Mayo Clinic News Ne

Updated on: March 13,2024

Neurologist explains aphasia

by Deb Balzer, Mayo Clinic News NetworkCredit: CC0 Public DomainAphasia is a condition that can affect a person's ability to communicate.To better understand the condition, the Mayo Clinic News Ne

Updated on:March 13,2024

Under 50 and overweight? Your odds for dementia later may rise

by Alan Mozes, Healthday Reporter(HealthDay)—Need fresh motivation to lose some weight? New research suggests that young adults who are overweight or obese face a higher risk for dementia in their gol

Updated on: March 19,2024

Under 50 and overweight? Your odds for dementia later may rise

by Alan Mozes, Healthday Reporter(HealthDay)—Need fresh motivation to lose some weight? New research suggests that young adults who are overweight or obese face a higher risk for dementia in their gol

Updated on:March 19,2024

AsEH enzyme: A new pharmacological target against Alzheimer's disease

by University of BarcelonaCredit: Unsplash/CC0 Public DomainA UB study published in the journalNeurotherapeuticshas validated a new pharmacological target for Alzheimer's disease.

Updated on: March 19,2024

AsEH enzyme: A new pharmacological target against Alzheimer's disease

by University of BarcelonaCredit: Unsplash/CC0 Public DomainA UB study published in the journalNeurotherapeuticshas validated a new pharmacological target for Alzheimer's disease.

Updated on:March 19,2024

Can highly superior autobiographic memory enhance creativity?

by BIAL FoundationCredit: Pixabay/CC0 Public DomainResearchers from universities in Italy and the U.S. studied the relationship between memory and creativity to assess whether those who remember the s

Updated on: February 05,2024

Can highly superior autobiographic memory enhance creativity?

by BIAL FoundationCredit: Pixabay/CC0 Public DomainResearchers from universities in Italy and the U.S. studied the relationship between memory and creativity to assess whether those who remember the s

Updated on:February 05,2024

Asymmetrical neuron loss in Alzheimer's

by Ludwig Maximilian University of MunichCredit: Christian Wachinger/LMUAs Alzheimer's disease progresses, neuron loss leads to marked lateral asymmetries in brain structure. A new LMU study

Updated on: March 09,2024

Asymmetrical neuron loss in Alzheimer's

by Ludwig Maximilian University of MunichCredit: Christian Wachinger/LMUAs Alzheimer's disease progresses, neuron loss leads to marked lateral asymmetries in brain structure. A new LMU study

Updated on:March 09,2024

New data resource for dementia research

by Oxford UniversityAn Oxford University-led research programme has launched a new system to help dementia researchers make the most of existing study data. The Dementias Platform UK's new&nb

Updated on: February 26,2024

New data resource for dementia research

by Oxford UniversityAn Oxford University-led research programme has launched a new system to help dementia researchers make the most of existing study data. The Dementias Platform UK's new&nb

Updated on:February 26,2024

Drop in mortality seen with AChEI, memantine in dementia with lewy bodies

by Elana GotkineFor patients with dementia with Lewy bodies (DLB), treatment with acetylcholinesterase inhibitors (AChEIs) and/or memantine is associated with reduced hospital admissions and mortality

Updated on: June 24,2024

Drop in mortality seen with AChEI, memantine in dementia with lewy bodies

by Elana GotkineFor patients with dementia with Lewy bodies (DLB), treatment with acetylcholinesterase inhibitors (AChEIs) and/or memantine is associated with reduced hospital admissions and mortality

Updated on:June 24,2024